SCHEMBL21090296

SCHEMBL21090296

N#Cc1ccc(-n2c3ccc(-c4ccccc4C#N)cc3c3cc(-c4ccccc4C#N)ccc32)c(-c2nc(-c3ccccc3)nc(-c3cc(C#N)ccc3-n3c4ccc(-c5ccccc5C#N)cc4c4cc(-c5ccccc5C#N)ccc43)n2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.39
CYP1A2 P05177 6/20 0.37
CYP3A4 P08684 6/20 0.37
HSD17B10 Q99714 5/20 0.37
HPGD P15428 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
KDM4E B2RXH2 2/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 1/20 0.37
TRPA1 O75762 1/20 0.37
ALDH1A1 P00352 5/20 0.36
CLK4 Q9HAZ1 3/20 0.36
MAPK1 P28482 2/20 0.36
GABRG2 P18507 5/20 0.36
GABRB3 P28472 5/20 0.36
GABRA1 P14867 4/20 0.36
GABRA2 P47869 4/20 0.36
GABRA5 P31644 4/20 0.36
GABRA3 P34903 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20156171 1.00 NR3C1 (0.39) NR3C1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL20156118 0.97 TRPA1 (0.38) NR3C1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL24924204 0.97 NR3C1 (0.37) NR3C1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL22243195 0.96 NR3C1 (0.39) NR3C1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL27019083 0.95 CYP1A2 (0.37) NR3C1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL27018420 0.95 TRPA1 (0.36) NR3C1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL21365074 0.95 NR3C1 (0.39) NR3C1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL27018255 0.94 TRPA1 (0.36) NR3C1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL24924888 0.94 CYP1A2 (0.36) NR3C1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL26052680 0.94 NR3C1 (0.38) NR3C1CYP1A2CYP3A4HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240074304-A1 ORGANIC ELECTROLUMINESCENT DEVICE EMITTING BLUE LIGHT SAMSUNG DISPLAY CO., LTD. (KR) 2024-02-29 US disclosed
US-20240032420-A1 ORGANIC ELECTROLUMINESCENT DEVICE EMITTING GREEN LIGHT SAMSUNG DISPLAY CO., LTD. (KR) 2024-01-25 US disclosed
US-20240032317-A1 ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2024-01-25 US disclosed
US-20230380199-A1 ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-23 US disclosed
US-20230371364-A1 ORGANIC ELECTROLUMINESCENT DEVICE EMITTING BLUE LIGHT SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-16 US disclosed
US-20230371364-A1 ORGANIC ELECTROLUMINESCENT DEVICE EMITTING BLUE LIGHT SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-16 US disclosed
US-20230371294-A1 ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-16 US disclosed
US-20230371294-A1 ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-16 US disclosed
US-20230363195-A1 ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-09 US disclosed
US-20230345750-A1 ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-26 US disclosed
US-20230345751-A1 ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-26 US disclosed
US-20230329021-A1 ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-12 US disclosed
US-20230329024-A1 ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-12 US disclosed
US-20230329022-A1 ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-12 US disclosed
US-20190177303-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190177303-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, ORC3, OR51E2 NR3C1 4329/4885CYP1A2 1161/4885CYP3A4 1274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.